Miller Joseph M's Form 4 filing
Aurinia Pharmaceuticals Inc. (AUPH) · filed Mar 4, 2025
- Accession no.
- 0001600620-25-000020
- Filed
- Mar 4, 2025
- Trade date
- Feb 28-Mar 4, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $939.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Miller Joseph MCIK 0001746372 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Common Stock | AGrant or awardAcquired | +81,457 | $0.00 | $0 | 580,663 | Direct | |
| Mar 3, 2025 | Common Stock | AGrant or awardAcquired | +114,711 | $0.00 | $0 | 695,374 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −61,859 | $8.00 | −$494,872 | 633,515 | Direct | |
| Mar 4, 2025 | Common Stock | SSaleDisposed | −56,154 | $7.92 | −$444,739.68 | 577,361 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Common Stock | AGrant or awardAcquired | +124,393 | $0.00 | $0 | 124,393 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.